Vertis Biotechnologie AG is a German biotechnology company that was founded in 2000 as a spin-off from the Technical University Munich-Weihenstephan. This company specializes in providing top-tier, rapid molecular biology services in functional genomics. Their pioneering technology platform significantly accelerates gene discovery projects. The products and services offered by VERTIS include cDNA synthesis, full-length cDNA cloning, cDNA library construction, cloning and analysis of small non-coding RNA (including microRNA), and profiling of gene expression using advanced ultra high-throughput MPSS DNA sequencing technology. Operating in the biotechnology and health care industries, Vertis Biotechnologie AG is based in Germany. As of now, there is no publicly disclosed information about their last investment or the investors involved.
There is no investment information
No recent news or press coverage available for Vertis Biotechnologie AG.
We care about your data, and we'd love to use cookies make your experience better.
